Log In
Print
BCIQ
Print
Print this Print this
 

IMS-088

  Manage Alerts
Collapse Summary General Information
Company ImStar Therapeutics Inc.
DescriptionSmall molecule derived from withaferin A
Molecular Target NF-kappa B (NF-kB) ; I-kappa B kinase (IKK)
Mechanism of ActionNF-kappa B (NF-kB) inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationAmyotrophic lateral sclerosis (ALS)
Indication DetailsTreat amyotrophic lateral sclerosis (ALS)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today